Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Drug stocks diverge; AstraZeneca declines
MarketWatch
Saturday, February 13, 2010 - 11:08am
tags:
AstraZeneca
Anacor: Merck returns fungal infection drug rights
Yahoo/AP
Saturday, February 13, 2010 - 11:07am
tags:
Anacor, Merck
Martek Closes on Purchase of Amerifit Brands, Inc.
Yahoo/PR NewsWire
Saturday, February 13, 2010 - 11:05am
tags:
Martek Biosciences, Amerifit Brands
Theravance Misses Estimates
Yahoo/Zacks
Saturday, February 13, 2010 - 10:51am
tags:
Theravance
ZymoGenetics Beats by a Penny
Yahoo/Zacks
Saturday, February 13, 2010 - 10:49am
tags:
ZymoGenetics
Curis lands $8M as cancer-drug trial advances
bizjournals.com
Saturday, February 13, 2010 - 10:46am
tags:
Curis, Debiopharm, cancer
Genzyme rivals unleash barrage of promising Gaucher data
Fierce Biotech
Friday, February 12, 2010 - 9:04am
tags:
Genzyme, Gaucher disease, Shire, Protalix BioTherapeutics
Former Schering CEO Hassan Sees More Deals Among Drugmakers
Bloomberg
Friday, February 12, 2010 - 9:02am
tags:
Schering Plough, Fred Hassan, M&A
China Amends Patent Law For Compulsory Licensing
Pharmalot
Friday, February 12, 2010 - 8:23am
tags:
licensing, China, patents
Call-Selling in Vanda Pharma
Seeking Alpha
Friday, February 12, 2010 - 8:22am
tags:
Vanda
Biotech Stock Mailbag: NexMed
TheStreet.com
Friday, February 12, 2010 - 8:19am
tags:
NexMed, Sequenom, Vivus, Keryx, Targacept, Immunogen, Cell Therapeutics
AstraZeneca Says ‘Don’t Judge’ Earnings for Payoff
Bloomberg
Friday, February 12, 2010 - 8:15am
tags:
David Brennan, AstraZeneca, earnings
Roche moleculor diagnostics unit sues Qiagen unit
Reuters
Friday, February 12, 2010 - 8:14am
tags:
Roche, Qiagen
Simcere Wins OK for Flu Drug Relenza
Seeking Alpha
Friday, February 12, 2010 - 8:08am
tags:
Simcere, Flu, RELENZA, GSK
Cephalon fourth-quarter profit jumps to $96.6 mln
Marketwatch
Friday, February 12, 2010 - 8:06am
tags:
Cephalon, earnings
Drugmaker Deal-Negotiator Tauzin to Step Down From Trade Group
Bloomberg
Friday, February 12, 2010 - 8:04am
tags:
Billy Tauzin, PhRMA
Abbott gets approval for new formula of HIV drug
Yahoo/AP
Friday, February 12, 2010 - 8:03am
tags:
HIV, Abbott Laboratories, Norvir
Investors Are Sick Of Boston Scientific
Forbes
Friday, February 12, 2010 - 8:03am
tags:
Boston Scientific
Safety Concerns Continue to Dog Isis, Genzyme Partnership
Seeking Alpha
Thursday, February 11, 2010 - 3:55pm
tags:
Genzyme, Isis Pharmaceuticals, partnerships, mipomersen
No generics push for AZ, Brennan says
Fierce Pharma
Thursday, February 11, 2010 - 3:50pm
tags:
AstraZeneca, generics, Pharma CEOs, David Brennan

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.